#21. IQVIA Holdings Inc (IQV) — 23% UPSIDE

IQVIA Holdings is a provider of analytics, technology solutions and contract research services to the life sciences industry. Co. is managed through three reportable segments: Technology and Analytics Solutions, which provides information, technology solutions and real-world insights and services to life science clients; Research and Development Solutions, which primarily serves biopharmaceutical clients, engaged in research and development and provides clinical research and clinical trial services; and Contract Sales and Medical Solutions, which provides contract sales to both biopharmaceutical clients and the healthcare market. The median 12 month forward target price among analysts covering IQV is $175.0/share.